{"transactions":[{"id":729458,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-23T21:22:35.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":29500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 18, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":29500,"derivative":{"exercise_price":9.51,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":29500},"source":{"system":"sec-edgar","filing":"0001162157-26-000002","document":"form4-06232026_090631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000116215726000002/form4-06232026_090631.xml","form_type":"4"}},{"id":989014,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T23:00:11.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":false,"shares":35868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.39,"expiration_date":"2025-12-20","underlying":"Common Stock","underlying_shares":35868},"source":{"system":"sec-edgar","filing":"0001162157-25-000005","document":"form4-11252025_061101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000116215725000005/form4-11252025_061101.xml","form_type":"4"}},{"id":989013,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:00:11.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":false,"shares":35868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person transferred 35,868 to the Rappaport Family Foundation, a charitable foundation of which the reporting person is an officer, as a bona fide gift for no consideration. The reporting person has voting and dispositive power over all securities owned by the foundation."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001162157-25-000005","document":"form4-11252025_061101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000116215725000005/form4-11252025_061101.xml","form_type":"4"}},{"id":989012,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:00:11.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":true,"shares":35868,"price":0.39,"value":13988.52,"ownership":{"direct":true},"balance_after":35868,"source":{"system":"sec-edgar","filing":"0001162157-25-000005","document":"form4-11252025_061101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000116215725000005/form4-11252025_061101.xml","form_type":"4"}},{"id":1112174,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T21:00:13.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":24150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 11, 2025, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":24150,"derivative":{"exercise_price":4.08,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24150},"source":{"system":"sec-edgar","filing":"0001415889-25-017232","document":"form4-06132025_050610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000141588925017232/form4-06132025_050610.xml","form_type":"4"}},{"id":1475874,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T21:00:23.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 14, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":23000,"derivative":{"exercise_price":12.36,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001415889-24-017447","document":"form4-06182024_050618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000141588924017447/form4-06182024_050618.xml","form_type":"4"}},{"id":1592246,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:36:05.000Z","date":"2024-03-05","kind":"other","planned":false,"acquired":true,"shares":385965,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution for no consideration from SPW Investments LLC (\"SPWI\") to its members. Skyline Public Works, LLC, of which the Reporting Person is a managing member, is the general partner of SPWI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by the Rappaport Family Trust, of which the reporting person is co-trustee."}],"balance_after":385965,"source":{"system":"sec-edgar","filing":"0001415889-24-007081","document":"form4-03062024_100356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000141588924007081/form4-03062024_100356.xml","form_type":"4"}},{"id":1592245,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:36:05.000Z","date":"2024-03-05","kind":"other","planned":false,"acquired":false,"shares":481014,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution for no consideration from SPW Investments LLC (\"SPWI\") to its members. Skyline Public Works, LLC, of which the Reporting Person is a managing member, is the general partner of SPWI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares were held by SPWI."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-007081","document":"form4-03062024_100356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000141588924007081/form4-03062024_100356.xml","form_type":"4"}},{"id":1848076,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-21T21:00:07.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":21520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 16, 2023, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":21520,"derivative":{"exercise_price":7.84,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":21520},"source":{"system":"sec-edgar","filing":"0001415889-23-010100","document":"form4-06212023_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000141588923010100/form4-06212023_050601.xml","form_type":"4"}},{"id":2221409,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-27T21:06:29.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":21520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed solely for the purpose of correcting the transaction date and exercise price. The correct transaction date is \"June 17, 2022\" and the correct exercise price is \"$3.61\" as shown herein."},{"field":"date","element":"transactionDate","label":"F1","text":"This amendment is being filed solely for the purpose of correcting the transaction date and exercise price. The correct transaction date is \"June 17, 2022\" and the correct exercise price is \"$3.61\" as shown herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 17, 2022, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":21520,"derivative":{"exercise_price":3.61,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":21520},"source":{"system":"sec-edgar","filing":"0001415889-22-006959","document":"form4a-06272022_020613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000141588922006959/form4a-06272022_020613.xml","form_type":"4/A","original_submission_date":"2022-06-17"}},{"id":2228401,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T23:27:30.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":21520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 16, 2022, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":21520,"derivative":{"exercise_price":3.43,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":21520},"source":{"system":"sec-edgar","filing":"0001415889-22-006783","document":"form4-06172022_040617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000141588922006783/form4-06172022_040617.xml","form_type":"4"}},{"id":2674270,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-10T22:35:22.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":21520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 9, 2021, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":21520,"derivative":{"exercise_price":27.66,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":21520},"source":{"system":"sec-edgar","filing":"0001415889-21-002923","document":"form4-06102021_030600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000141588921002923/form4-06102021_030600.xml","form_type":"4"}},{"id":2970095,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2020-11-23T21:35:09.000Z","date":"2020-11-23","kind":"exercise","acquired":false,"shares":129833,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by SPW Investments LLC (\"SPWI\"). Skyline Public Works, LLC, of which the Reporting Person is a managing member, is the general partner of SPWI."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":129833},"source":{"system":"sec-edgar","filing":"0001209191-20-059978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000120919120059978/doc4.xml","form_type":"4"}},{"id":2970094,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-11-23T21:35:09.000Z","date":"2020-11-23","kind":"exercise","acquired":false,"shares":318723,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by SPW Investments LLC (\"SPWI\"). Skyline Public Works, LLC, of which the Reporting Person is a managing member, is the general partner of SPWI."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":318723},"source":{"system":"sec-edgar","filing":"0001209191-20-059978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000120919120059978/doc4.xml","form_type":"4"}},{"id":2970093,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-23T21:35:09.000Z","date":"2020-11-23","kind":"exercise","acquired":true,"shares":129833,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by SPW Investments LLC (\"SPWI\"). Skyline Public Works, LLC, of which the Reporting Person is a managing member, is the general partner of SPWI."}],"balance_after":481014,"source":{"system":"sec-edgar","filing":"0001209191-20-059978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000120919120059978/doc4.xml","form_type":"4"}},{"id":2970092,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-23T21:35:09.000Z","date":"2020-11-23","kind":"exercise","acquired":true,"shares":318723,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by SPW Investments LLC (\"SPWI\"). Skyline Public Works, LLC, of which the Reporting Person is a managing member, is the general partner of SPWI."}],"balance_after":351181,"source":{"system":"sec-edgar","filing":"0001209191-20-059978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000120919120059978/doc4.xml","form_type":"4"}},{"id":2973438,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-20T00:00:19.000Z","date":"2020-11-18","kind":"grant","acquired":true,"shares":21520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in a series of 12 successive equal monthy installments measured from June 1, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":21520,"derivative":{"exercise_price":19,"expiration_date":"2030-11-17","underlying":"Common Stock","underlying_shares":21520},"source":{"system":"sec-edgar","filing":"0001209191-20-059526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000120919120059526/doc4.xml","form_type":"4"}},{"id":2973437,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":36082,"kind":"person","name":"RAPPAPORT ANDREW","position":1,"cik":"0001162157","reported_name":"RAPPAPORT ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-20T00:00:19.000Z","date":"2020-09-18","kind":"grant","acquired":true,"shares":56964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested."}],"balance_after":56964,"derivative":{"exercise_price":4.824,"expiration_date":"2030-09-17","underlying":"Common Stock","underlying_shares":56964},"source":{"system":"sec-edgar","filing":"0001209191-20-059526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162157/000120919120059526/doc4.xml","form_type":"4"}}]}